Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis

Lung adenocarcinoma (LUAD) is the most common and aggressive subtype of lung cancer with the greatest heterogeneity and aggression. Inspite of recent years’ achievements in understanding the pathogenesis of this disease, as well as the development of new therapeutic approaches, our knowledge on cruc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongming, Guo, Liting, Chen, Jibei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166063/
https://www.ncbi.nlm.nih.gov/pubmed/32341654
http://dx.doi.org/10.2147/OTT.S248436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166063/
https://www.ncbi.nlm.nih.gov/pubmed/32341654
http://dx.doi.org/10.2147/OTT.S248436

Ejemplares similares